Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
HEC Pharm Logo
HEC Pharm Growth Score
78
CB Rank
168373
Heat Score
47
HEC Pharm is a Chinese drugmaker company.
Founded
obfuscation
PublicPost-IPO Equity Dongguang, Guangdong, China1001-5000 www.hecpharm.com
Manufacturing
Medical
Pharmaceutical
Overview

HEC Pharm
Total Funding
obfuscation
Growth Score
78
Heat Score
47

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score78
-8 pts
in past quarter
Heat Score 47
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About HEC Pharm

CB Rank
168373
HEC Pharm is a Chinese drugmaker company.
Founded
obfuscation
PublicPost-IPO Equity Dongguang, Guangdong, China1001-5000 www.hecpharm.com
Manufacturing
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Guangdong Dongyangguang Pharmaceutical Co., Ltd
Also Known As Guangdong Dongyangguang Pharmaceutical
Operating Status Active
Stock Symbol  HKG:1558
Company Type For Profit
About the Company
HEC Pharm is a private company, which was founded in 1992 in Shenzhen, China which is active in three areas: aluminum, nanling resorts and pharmaceuticals. HEC Pharm , with a turnover of 2 billion U.S. dollars (2011) was one of the top 50 private enterprises in China.
Phone Number +86 769-85370280
Contact Email info@hec.cn
Predictions & Insights

Growth Insight

See this Growth Insight
HEC Pharm is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Oseltamivir Phosphate Granules (Kewei)
An antiviral medication for treating influenza A and B in adults and children over 1 year, to be used within 48 hours of symptom onset.
Oseltamivir Phosphate Capsules (Kewei)
Capsule form of oseltamivir phosphate for treating influenza A and B in adults and children over 1 year, used within 48 hours of symptom onset.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity
obfuscation
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
1
obfuscation
Blackstone GroupPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Blackstone Group Logo
Blackstone Group
Yes
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
—
Blackstone Group Logo
Blackstone Group
Yes
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
—
Blackstone Group Logo
Blackstone Group
Yes
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
—
Blackstone Group Logo
Blackstone Group
Yes
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
—
Blackstone Group Logo
Blackstone Group
Yes
Post-IPO Equity - HEC Pharm Logo
Post-IPO Equity - HEC Pharm
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,040
-59.48%
 in past month

IT Spend

$982.7KThis year, HEC Pharm is projected to spend $982.7K on IT, according to Aberdeen.

Active Website Tech Count

6HEC Pharm is actively using 6 technologies for its website, according to BuiltWith. These include SSL by Default, Euro, and  SPF.

Total IP

4The intellectual property of HEC Pharm includes 4 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is HEC Pharm's headquarters? HEC Pharm is located in Dongguang, Guangdong, China.Who invested in HEC Pharm? HEC Pharm is funded by Blackstone Group.When was the last funding round for HEC Pharm? HEC Pharm closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are HEC Pharm's competitors? Alternatives and possible competitors to HEC Pharm may include Gilead Sciences, Virtu Pharmako, and  Huisheng Biopharmaceutical.How much funding has HEC Pharm raised to date? HEC Pharm has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|